» Articles » PMID: 29482609

MicroRNA-302b Negatively Regulates IL-1β Production in Response to MSU Crystals by Targeting IRAK4 and EphA2

Overview
Publisher Biomed Central
Specialty Rheumatology
Date 2018 Feb 28
PMID 29482609
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Interleukin-1β (IL-1β) is a pivotal proinflammatory cytokine that is strongly associated with the inflammation of gout. However, the underlying mechanism through which the production of IL-1β is regulated has not been fully elucidated. Our previous work identified that miR-302b had an important immune regulatory role in bacterial lung infections. This study was conducted to evaluate the function of miR-302b on monosodium urate (MSU) crystal-induced inflammation and its mechanism.

Methods: The expression pattern and the immune-regulatory role of miR-302b were evaluated both in vitro and in vivo. The functional targets of miR-302b were predicted by bioinformatics, and then validated by genetic approaches. In addition, the clinical feature of miR-302b was analyzed using serum samples of patients with gouty arthritis.

Results: The extremely high expression of miR-302b was observed in both macrophages and mouse air membranes treated with MSU. Intriguingly, overexpression of miR-302b regulated NF-κB and caspase-1 signaling, leading to significantly attenuate MSU-induced IL-1β. By genetic analysis, miR-302b exhibited inhibitory function on IRAK4 and EphA2 by binding to their 3'-UTR regions. Corporately silencing IRAK4 and EphA2 largely impaired MSU-induced IL-1β protein production. Moreover, it was also found that miR-302b and EphA2 suppressed the migration of macrophages. Finally, it was observed that high expression of miR-302b was a general feature in patients with gouty arthritis.

Conclusions: These results suggest that miR-302b can regulate IL-1β production in MSU-induced inflammation by targeting NF-κB and caspase-1 signaling, and may be a potential therapeutic target for gouty arthritis.

Citing Articles

Perspectives in MicroRNA Therapeutics for Cystic Fibrosis.

Finotti A, Gambari R Noncoding RNA. 2025; 11(1.

PMID: 39846681 PMC: 11755495. DOI: 10.3390/ncrna11010003.


Mechanism of macrophages in gout: Recent progress and perspective.

Tan H, Zhang S, Liao J, Qiu X, Zhang Z, Wang Z Heliyon. 2024; 10(19):e38288.

PMID: 39386881 PMC: 11462003. DOI: 10.1016/j.heliyon.2024.e38288.


Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells.

Mancuso R, Citterio L, Agostini S, Marventano I, La Rosa F, Re F Pharmaceuticals (Basel). 2023; 16(11).

PMID: 38004455 PMC: 10675475. DOI: 10.3390/ph16111590.


Sirt3 improves monosodium urate crystal-induced inflammation by suppressing Acod1 expression.

Lv L, Jiang H, Song D, Zhou X, Chen F, Ren L Arthritis Res Ther. 2023; 25(1):121.

PMID: 37468929 PMC: 10354977. DOI: 10.1186/s13075-023-03107-6.


Regulation of Inflammasome by microRNAs in Triple-Negative Breast Cancer: New Opportunities for Therapy.

Balahura Stamat L, Dinescu S, Costache M Int J Mol Sci. 2023; 24(4).

PMID: 36834660 PMC: 9963301. DOI: 10.3390/ijms24043245.


References
1.
Hong J, Shin M, Chung K, Kim E, Jung J, Kang Y . EphA2 Receptor Signaling Mediates Inflammatory Responses in Lipopolysaccharide-Induced Lung Injury. Tuberc Respir Dis (Seoul). 2015; 78(3):218-26. PMC: 4499589. DOI: 10.4046/trd.2015.78.3.218. View

2.
Vicente R, Noel D, Pers Y, Apparailly F, Jorgensen C . Deregulation and therapeutic potential of microRNAs in arthritic diseases. Nat Rev Rheumatol. 2015; 12(4):211-20. DOI: 10.1038/nrrheum.2015.162. View

3.
Martin W, Harper J . Innate inflammation and resolution in acute gout. Immunol Cell Biol. 2009; 88(1):15-9. DOI: 10.1038/icb.2009.89. View

4.
Okazaki T, Ni A, Baluk P, Ayeni O, Kearley J, Coyle A . Capillary defects and exaggerated inflammatory response in the airways of EphA2-deficient mice. Am J Pathol. 2009; 174(6):2388-99. PMC: 2684202. DOI: 10.2353/ajpath.2009.080949. View

5.
Chen K, Rajewsky N . The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet. 2007; 8(2):93-103. DOI: 10.1038/nrg1990. View